A New Dawn
Leading innovation in perfusion technology
Supporting some of America's most accomplished surgeons, physicians, and scientists by creating the ‘tools’ needed to perfuse and preserve a wide variety of organs and tissue ex vivo—out of the body—allowing them to advance drug and gene therapy research, technology that is now set to transform the world of organ transplant.
Experts in high control, low pressure, air, and fluid flow technology solutions, with one of our many patented technologies, emulating the “push and pull” of the cardiovascular system, providing the very ‘heart’ for a series of commercial products and newly emerging devices.
Our Management Team
7 years COO and GM experience in perfusion technology
Leading research and innovation expert in perfusion technology
Significant knowledge and network within the medical arena.
Led national and Federal award winning response to COVID-19 crisis
Leading research and innovation expert in perfusion technology
Significant knowledge and network within the medical arena.
Led national and Federal award winning response to COVID-19 crisis
25+ years of life science experience, including over 20 years with Johnson & Johnson, a leading pharmaceutical and medical device company.
Wide range of leadership positions in the commercialization and development of drugs and devices. Notable career experiences include planning launches for novel devices and drugs, establishing research, development and commercial partnerships, and overseeing payor strategy and patient support services for a multi-billion-dollar product franchise. Co-invented and led the development of a diagnostic device now under ongoing approval by regulators around the globe.
Bachelor of Science in Chemical Engineering from Rice University and MBA from Columbia Business School.
Distinguished Professor and Vice Chair Clinical Affairs and Chief of the Division of Abdominal Transplant at UNC.
2020, US Secretary of Defense awarded the Defense Meritorious Service Medal to Dr. Gerber for exceptionally meritorious service for the Armed Forces.
In 2010 David was appointed by the Secretary of the Department of Health and Human Services (HHS) to the Advisory Committee on Transplantation.
One of America’s foremost expert perfusionists
14 years from research and development of perfusion tech
Co-author of many peer reviewed publications and papers
Leading the BMI lab at Duke Hospital
14 years from research and development of perfusion tech
Co-author of many peer reviewed publications and papers
Leading the BMI lab at Duke Hospital
World leading expert in design and development of advanced and automated perfusion systems
30+ years of engineering experience from US security clearance systems
US veteran who has held security clearance
30+ years of engineering experience from US security clearance systems
US veteran who has held security clearance
30+ years of advanced medical program development and engineering
Worked on multiple groundbreaking medical advancement systems
Worked on multiple groundbreaking medical advancement systems
25+ years executive experience in strategic business development in multiple jurisdictions
Special Advisor on Capitol Hill
Government and key stakeholder relations specialist
Helped forge industry/academic partnerships and PPP’s
Mark helped forge BMI’s relationships with Dr. Prabir Roy-Chaudhury MD, Ph.D, FRCP, co-Director of the Kidney Center UNC Chapel Hill, and with Dr. Tony Atala, MD, founding Director of the Wake Forest Institute of Regenerative Medicine, and negotiated the establishment of a new Recove laboratory based at the WFIRM ReMDO RegeneratOR in Winston-Salem.
Special Advisor on Capitol Hill
Government and key stakeholder relations specialist
Helped forge industry/academic partnerships and PPP’s
Mark helped forge BMI’s relationships with Dr. Prabir Roy-Chaudhury MD, Ph.D, FRCP, co-Director of the Kidney Center UNC Chapel Hill, and with Dr. Tony Atala, MD, founding Director of the Wake Forest Institute of Regenerative Medicine, and negotiated the establishment of a new Recove laboratory based at the WFIRM ReMDO RegeneratOR in Winston-Salem.
Medical & Scientific Advisory Board
Board-certified Kidney/Pancreas Transplant Surgeon, Liver Transplant Surgeon, Pediatric Kidney Transplant Surgeon, Pediatric Liver Transplant Surgeon with Duke University Hospital
Leads Duke Ex-Vivo Organ Laboratory (DEVOL), focused on laboratory development of novel strategies to enhance the function of high-risk transplanted organs.
Recipient of multiple national grant awards and cited in multiple peer review publications
Government and key stakeholder relations specialist
Helped forge industry/academic partnerships and PPP’s
Distinguished Professor and Vice Chair Clinical Affairs and Chief of the Division of Abdominal Transplant at UNC.
2020, US Secretary of Defense awarded the Defense Meritorious Service Medal to Dr. Gerber for exceptionally meritorious service for the Armed Forces.
In 2010 David was appointed by the Secretary of the Department of Health and Human Services (HHS) to the Advisory Committee on Transplantation.
Professor of Medicine, Division of Nephrology and Hypertension, Co-Director, UNC Kidney Center and leading transplant nephrologist
Founding co-Chair of the Kidney Health Initiative which is a public-private partnership between the American Society of Nephrology (ASN) and the FDA
Leads research programs funded by NIH, the VA and industry partners; has published over 175 papers; sought after speaker
Associate Professor of Surgery, Duke University School of Medicine, Division Cardiovascular and Thoracic Surgery
Board-certified thoracic surgeon with Duke University Hospital
Leads national and international efforts to develop new treatments for patients with diseases within the chest
Recipient of many national grant awards and cited in multiple peer review publications
Hepatologist at The Transplant Center, Presbyterian St. Luke’s Medical Center, Denver
Editor-in-Chief for the journal Hepatic Medicine: Evidence and Research
Formerly Associate Professor of Medicine at Weill Cornell Medical Center and Center for the Study of Hepatitis C with Charles M. Rice (Nobel Laureate 2020), and
Associate Professor of Medicine at Harvard Medical School
Our Partners
Duquesne University
Duke University
ExVivo Organ Lab (“DEVOL”)
RegenMed Development Organization (ReMDO)
Atrium Health,
Wake Forest Institute of Regenerative Medicine (“WFIRM”)
Department of Defense
Armed Forces Institute for Regenerative Medicine (AFRIM)
UNC Kidney Center
US National Lab
Department of Energy
Department of Neuroscience, Yale School Of Medicine, Sestan Lab
